The Mark H Zangmeister Cancer Center — Nashville, Tennessee

The Mark H Zangmeister Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

The Mark H Zangmeister Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Neoplasms, Neoplasm Metastasis.

Sponsors: Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nashville

Browse all research sites in Tennessee · View every site in Nashville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Mark H Zangmeister Cancer Center?

The Mark H Zangmeister Cancer Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Mark H Zangmeister Cancer Center conducted?

The Mark H Zangmeister Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Breast Neoplasms, Neoplasm Metastasis.

Is The Mark H Zangmeister Cancer Center accredited by Crixeo Clinical Trials?

The Mark H Zangmeister Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Mark H Zangmeister Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.